Brief: Kalvista Pharmaceuticals Q1 Net Income USD -40.443 Million
Sep 05 (Reuters) - Kalvista Pharmaceuticals Q1 basic EPS USD -0.87. * Q1 operating expenses USD 44.215 million * Q1 operating income USD -44.215 million
Recent news on Kalvista Pharmaceuticals
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 08:36 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Deals of the day-Mergers and acquisitions
U.S. STOCKS ON THE MOVE-Seagate, GE Healthcare, Bloom Energy